======================================================================== SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------------------------- FORM 10-QSB/A AMENDMENT NO. 1 (Mark One) /x/ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 1996 OR / / TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ---------- to ---------------- Commission File Number: 1-11765 MEDJET INC. (Exact name of Small Business Issuer as Specified in its Charter) DELAWARE 22-3283541 (State or Other Jurisdiction (I.R.S. Employer Identification No.) of Incorporation or Organization) 1090 KING GEORGES POST ROAD, SUITE 301 EDISON, NEW JERSEY 08837 (Address of Principal Executive Offices) (908) 738-3990 (Registrant's Telephone Number, Including Area Code) ---------------------------------------------------- (Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report Check whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. [ ] Yes [ X ] No Common Stock, par value $.001 per share, outstanding as of September 13, 1996: 3,682,455 shares. Units, each consisting of one share of Common Stock and one warrant to purchase one share of common stock outstanding as of September 13, 1996: 1,232,143 Units Transitional Small Business Disclosure format: [ ] Yes [ X ] No ======================================================================== This Amendment No. 1 to the Quaterly Report on Form 10-QSB of Medjet Inc. (the "Company") is being filed solely for the purpose of filing Exhibit 27, the Financial Data Schedule. Item 6. EXHIBITS. (a) EXHIBITS 27. Financial Data Schedule SIGNATURE --------- Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Dated: November 5, 1996 MEDJET INC. ----------------------------------- (Registrant) /s/ Eugene I. Gordon ----------------------------------- Eugene I. Gordon President and Chief Executive Officer /s/ Thomas M. Handschiegel ------------------------------------ Thomas M. Handschiegel Chief Financial Officer and Chief Accounting Officer EXHIBIT INDEX Sequentially No. Description Numbered Pages - --- ----------- -------------- 27. Financial Data Schedule